The content on this site is intended for healthcare professionals only
Prof Tripathy speaks with ecancertv at the Best of ASCO 2016 about modern attitudes to breast cancer care.
He outlines improvements that could help advance patient outcomes, including better modelling options and enhanced immune availability.
Prof Tripathy also considers the evolution of resistance in tumour cells, and of mutations that may be targeted by new therapies.
For more on breast cancer care via the MINDACT trial, click here.
Transforming cancer care in India: The Access Cancer Care Initiative
Burden and trends of breast cancer worldwide: Opportunities for prevention?
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Lung Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Overview of the management of HER2-low breast cancer patients
